99mTc-MAEC complexes: New renal radiopharmaceuticals combining characteristics of 99mTc-MAG3 and 99mTc-EC

Journal of Nuclear Medicine

Volumn 45, Issue 5, 2004, Pages 885-891

  Taylor, Andrew T ^a,c   Lipowska, Malgorzata ^a   Hansen, Lory ^a   Malveaux, Eugene ^a   Marzilli, Luigi G ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

99mTc ethylenedicysteine; 99mTc mercaptoacetamide ethylene cysteine; 99mTc mercaptoacetyltriglycine; Renal radiopharmaceuticals

Indexed keywords

MERCAPTOACETAMIDE ETHYLENE CYSTEINE TC 99M; TRACER; UNCLASSIFIED DRUG; CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; IODOHIPPURIC ACID; MERTIATIDE TC 99M; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M ETHYLENEDICYSTEINE; TECHNETIUM TC 99M-ETHYLENEDICYSTEINE;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CHEMICAL STRUCTURE; IN VIVO STUDY; KIDNEY CLEARANCE; KINETICS; NONHUMAN; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; RAT; ANIMAL; HUMAN; KIDNEY; SCINTISCANNING; SPRAGUE DAWLEY RAT; TISSUE DISTRIBUTION;

ANIMALS; CYSTEINE; HUMANS; IODINE RADIOISOTOPES; IODOHIPPURIC ACID; KIDNEY; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM TC 99M MERTIATIDE; TISSUE DISTRIBUTION;

EID: 2642552417     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Fritzberg AR, Kasina S, Eshima D, Johnson DL. Synthesis and biological evaluation of technetium-99m MAG3 as a hippuran replacement. J Nucl Med. 1986;27:111-116.
2. Eshima D, Taylor A. Technetium-99m mercaptoacetyltriglycine: update on the new Tc-99m renal tubular function agent. Semin Nucl Med. 1992;22:61-73.
3. Hansen L, Marzilli LG, Taylor A. The influence of stereoisomerism on the pharmacokinetics of Tc radiopharmaceuticals. Q J Nucl Med. 1998;42:280-293.
4. Cosgriff PS, Lawson RS, Nimmon CC. Towards standardization in gamma camera renography. Nucl Med Commun. 1992;13:580-585.
5. O'Reilly P, Aurell M, Britton K, Kletter K, Rosenthal L, Testa T. Consensus on diuresis renography for investigating the dilated upper urinary tract. J Nucl Med. 1996;37:1872-1876.
6. Gordon I, Colarinha P, Fettich J, et al. Guidelines for standard and diuretic renography in children. Eur J Nucl Med. 2001;28:BP21-BP30.
7. Taylor A, Eshima D, Fritzberg AR, Kasina S, Christian PE. Preliminary evaluation of Tc-99m mercaptoacetyltriglycine as a replacement for I-131 OIH. Contrib Nephrol. 1987;56:38-46.
8. Taylor A, Eshima D, Christian PE, Wooten W, Hansen L, McElvany K. A technetium-99m MAG3 kit formulation: preliminary results in normal volunteers and patients with renal failure. J Nucl Med. 1988;29:616-622.
9. Dogan A, Kirchner P. Hepatobiliary excretion of MAG3: simulation of a urinary leak. Clin Nucl Med. 1993;18:746-750.
10. Shattuck LA, Eshima D, Taylor AT, et al. Evaluation of the hepatobiliary excretion of Tc-99m MAG3 and reconstitution factors affecting the radiochemical purity. J Nucl Med. 1994;35:349-355.
11. 99mTc-ECD and their metabolites in mice. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and Rhenium in Chemistry and Nuclear Medicine 3. Verona, Italy: Cortina International; 1990:445-452.
12. Verbruggen AM, Nosco DL, Van Nerom CG, Bormans GM, Adriaens PJ, De Roo MJ. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals. J Nucl Med. 1992;33:551-557.
13. Van Nerom CG, Bormans GM, De Roo MJ, Verbruggen AM. First experience in healthy volunteers with technetium-99m L,L-ethylenedicysteine, a new renal imaging agent. Eur J Nucl Med. 1993;20:738-746.
14. Kabasakal L, Atay S, Vural AV, et al. Evaluation of technetium-99m- ethylenedicysteine in renal disorders and determination of extraction ratio. J Nucl Med. 1995;36:1398-1403.
15. Taylor A, Hansen L, Eshima D, et al. Comparison of technetium-99m-LL-EC isomers in rats and humans. J Nucl Med. 1997;38:821-826.
16. 2 chelate ligands. Inorg Chem. 1994;33:4850-4860.
17. 2 radiopharmaceuticals. In: Nicolini M, Bandoli G, Mazzi U, eds. Technetium and Rhenium in Chemistry and Medicine 4. Padova, Italy: Servizi Grafici Editoriali; 1995:27-32.
18. 2 ligands. J Am Chem Soc. 1997;38:8965-8972.
19. Hansen L, Taylor A Jr, Marzilli LG. Structural characterization of the rhenium( V) oxo complex of mercaptoacetyltriglycine in its dianionic form. Metal-Based Drugs. 1995;2:105-110.
20. y)complexes (M = Re, Tc). In: Mazzi U, Nicolini M, eds. Technetium and Rhenium in Chemistry and Medicine 5. Padova, Italy: Servizi Grafici Editoriali; 1999:19-26.
21. 2 ligand having carboxyl groups anti to the oxo group. Inorg Chem. 2000;39:5731-5740.
22. 2. Inorg Chem. 1995;34:3579-3580.
23. 2) radiopharmaceutical analogues as revealed by a novel dominant tautomer in the solid state. Inorg Chem. 1999;38:5351-5358.
24. 99mTc renal imaging agents: characterization by NMR spectroscopy, molecular mechanics calculations, and X-ray crystallography. Inorg Chim Acta. 2002;339:327-340.
25. Sapirstein LA, Vidt DG, Mandel MJ, Hanusek G. Volumes of distribution and clearances of intravenously injected creatinine in the dog. Am J Physiol. 1955;181:330-336.
26. 3, iodine-131 OIH and iodine-125 iothalamate. J Nucl Med. 1988;29:669-675.
27. Fritzberg AR, Kuni CC, Klingensmith WC III, Stevens J, Whitney WP. Synthesis and biological evaluation of Tc-99m N,N′-bis-(mercaptoacetyl)-2, 3-diaminopropionate: a potential replacement for I-131 hippuran. J Nucl Med. 1982;23:592-598.
28. Verbruggen A, Bormans G, Cleynhens B, Hoogmartens M, Vandercruys A, De Roo M. Separation of the enantiomers of technetium-99m-MAG3 and their renal excretion in baboons and a volunteer [abstract]. Eur J Nucl Med. 1988;15:256.